Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

October 7, 2025

Study Completion Date

October 7, 2025

Conditions
Liposarcoma, Dedifferentiated
Interventions
DRUG

Brigimadlin

Brigimadlin

Trial Locations (56)

2031

Prince of Wales Hospital-Randwick-66496, Randwick

3000

Peter MacCallum Cancer Centre, Melbourne

4102

Princess Alexandra Hospital, Woolloongabba

6009

Sir Charles Gairdner Hospital, Nedlands

10065

Memorial Sloan-Kettering Cancer Center, New York

11042

Northwell Health, Lake Success

19106

Abramson Cancer Center at Pennsylvania Hospital, Philadelphia

22031

Virginia Cancer Specialists, PC, Fairfax

27710

Duke University Medical Center, Durham

30607

University Cancer and Blood Center, Athens

32224

Mayo Clinic - Florida, Jacksonville

35249

University of Alabama at Birmingham, Birmingham

38138

West Cancer Center & Research Institute, Germantown

53226

Froedtert and The Medical College of Wisconsin, Milwaukee

55905

Mayo Clinic, Rochester, Rochester

60611

Northwestern University, Chicago

63108

Washington University School of Medicine, St Louis

66210

University of Kansas Cancer Center, Overland Park

68114

Nebraska Methodist Hospital, Omaha

77030

The University of Texas MD Anderson Cancer Center, Houston

84106

Utah Cancer Specialists Cancer Center, Salt Lake City

84112

Huntsman Cancer Institute, Salt Lake City

85054

Mayo Clinic-Arizona, Phoenix

90212

Precision NextGen Oncology, Beverly Hills

90403

Sarcoma Oncology Center, Santa Monica

90404

University of California Los Angeles, Santa Monica

98109

Fred Hutchinson Cancer Research Center, Seattle

99208

Medical Oncology Associates, P.S., Spokane

06510

Yale Cancer Center, New Haven

07601

John Theurer Cancer Center, Hackensack

1280AEB

Hospital Britanico de Buenos Aires, CABA

C1120AAB

Sanatorio Finochietto, CABA

C1199ABB

Hospital Italiano de Buenos Aires, CABA

C1426ANZ

Instituto Medico Especializado Alexander Fleming, Ciudad Autonoma de Bs As

60810-180

Pronutrir, Fortaleza

86015-520

Hospital do Cancer de Londrina, Londrina

09060-650

CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia, Santo André

65060-645

Hospital Sao Domingos, São Luís

01323-001

H.S.J. Beneficência Portuguesa - São Paulo, São Paulo

T2N 5G2

Arthur J. E. Child Comprehensive Cancer Centre, Calgary

M5G 2M9

Princess Margaret Cancer Centre, Toronto

H4A 3J1

McGill University Health Centre (MUHC), Montreal

464-8681

Aichi Cancer Center Hospital, Aichi, Nagoya

466-8560

Nagoya University Hospital, Aichi, Nagoya

277-8577

National Cancer Center Hospital East, Chiba, Kashiwa

811-1395

National Hospital Organization Kyushu Cancer Center, Fukuoka, Fukuoka

812-8582

Kyushu University Hospital, Fukuoka, Fukuoka

980-8574

Tohoku University Hospital, Miyagi, Sendai

700-8558

Okayama University Hospital, Okayama, Okayama

541-8567

Osaka International Cancer Institute, Osaka, Osaka

003-0804

Hokkaido Cancer Center, Sapporo, Hokkaido

135-8550

Japanese Foundation for Cancer Research, Tokyo, Koto-ku

CB2 0QQ

Addenbrooke's Hospital, Cambridge

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

SW3 6JJ

The Royal Marsden Hospital, Chelsea, London

M20 4BX

The Christie, Manchester

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY